Childhood Myopia Part II: Treatment Mechanisms, Emerging Options, and Considerations

https://iovs.arvojournals.org/article.aspx?articleid=2803078

Childhood Myopia Part I: Contemporary Treatment Options

Safal Khanal, Erin S. Tomiyama, Síofra C. Harrington; Childhood Myopia Part I: Contemporary Treatment Options. Invest. Ophthalmol. Vis. Sci.2025;66(7):6. https://doi.org/10.1167/iovs.66.7.6.https://iovs.arvojournals.org/article.aspx?articleid=2803079

IMI—Onset and Progression of Myopia in Young Adults

Mark A. Bullimore, Samantha Sze-Yee Lee, Katrina L. Schmid, Jos J. Rozema, Nicolas Leveziel, Edward A. H. Mallen, Nina Jacobsen, Rafael Iribarren, Pavan K. Verkicharla, Jan Roelof Polling, Paul Chamberlain; IMI—Onset and Progression of Myopia in Young Adults. Invest. Ophthalmol. Vis. Sci.2023;64(6):2. https://doi.org/10.1167/iovs.64.6.2.

https://iovs.arvojournals.org/article.aspx?articleid=2785578

https://iovs.arvojournals.org/article.aspx?articleid=2785578

Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia

Markakis, D., Britten-Jones, A.C., Guymer, R.H. et al. Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia. Sci Rep 15, 8528 (2025). https://doi.org/10.1038/s41598-025-90516-z

https://www.nature.com/articles/s41598-025-90516-z.pdf

Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended Usage

Ian Flitcroft, Mark A. Bullimore, Kate L. Gifford, Jost B. Jonas, Deborah Jones, Lyndon W. Jones, Pauline Kang, Serge Resnikoff, Jeffrey Walline, Christine F. Wildsoet, On behalf of the International Myopia Institute (IMI); Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended Usage. Invest. Ophthalmol. Vis. Sci. 2025;66(6):41. https://doi.org/10.1167/iovs.66.6.41.

https://elifesciences.org/download/aHR0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0aWNsZXMvOTgxNDMvZWxpZmUtOTgxNDMtdjEucGRmP2Nhbm9uaWNhbFVyaT1odHRwczovL2VsaWZlc2NpZW5jZXMub3JnL2FydGljbGVzLzk4MTQz/elife-98143-v1.pdf?_hash=fic3Uq7omxPpoBTFr66N5ML6vIHEKNQ2g4PjkRrwRLQ%3D

Altered visual cortex excitatory/inhibitory ratio following transient congenital visual deprivation in humans

Pant R, Pitchaimuthu K, Ossandón JP, Shareef I, Lingareddy S, Finsterbusch J, Kekunnaya R, Röder B. Altered visual cortex excitatory/inhibitory ratio following transient congenital visual deprivation in humans. Elife. 2025 May 16;13:RP98143. doi: 10.7554/eLife.98143. PMID: 40377962; PMCID: PMC12084009.

https://elifesciences.org/download/aHR0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0aWNsZXMvOTgxNDMvZWxpZmUtOTgxNDMtdjEucGRmP2Nhbm9uaWNhbFVyaT1odHRwczovL2VsaWZlc2NpZW5jZXMub3JnL2FydGljbGVzLzk4MTQz/elife-98143-v1.pdf?_hash=fic3Uq7omxPpoBTFr66N5ML6vIHEKNQ2g4PjkRrwRLQ%3D

Effect of Myopic Defocus on the Retina and Choroid and Its Interaction with Defocus Regions, Diurnal Rhythm, and Accommodation

Huang Y, Zhang J, Li X, Chen H, Bao J. Effect of Myopic Defocus on the Retina and Choroid and Its Interaction with Defocus Regions, Diurnal Rhythm, and Accommodation. Ophthalmol Sci. 2025 Mar 21;5(5):100773. doi: 10.1016/j.xops.2025.100773. PMID: 40375873; PMCID: PMC12076711.

https://www.ophthalmologyscience.org/action/showPdf?pii=S2666-9145%2825%2900071-5

Microvascular Changes in Full-Thickness Macular Hole Patients Before and After Vitrectomy: An Optical Coherence Tomography-Angiography Study

Górska A, Sirek S, Woszczek D, Leszczyński R. Microvascular Changes in Full-Thickness Macular Hole Patients Before and After Vitrectomy: An Optical Coherence Tomography-Angiography Study. Clin Pract. 2025 Mar 11;15(3):58. doi: 10.3390/clinpract15030058. PMID: 40136594; PMCID: PMC11941384.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11941384/pdf/clinpract-15-00058.pdf

Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine

Guemes-Villahoz N, Talavero González P, Porras-Ángel P, Bella-Gala R, Ruiz-Pomeda A, Martin-Garcia B, Hernandez-Garcia E, Gomez de Liaño N, Shah R, Garcia-Feijoo J, Gomez-de-Liaño R. Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine. Br J Ophthalmol. 2025 May 9:bjo-2024-326852. doi: 10.1136/bjo-2024-326852. Epub ahead of print. PMID: 40345841.https://bjo.bmj.com/content/bjophthalmol/early/2025/05/08/bjo-2024-326852.full.pdf

A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migraine

https://www.optometrytimes.com/view/treating-ded-can-reduce-migraine-severity-according-to-study

Md Isa, Nur Amalina MOptom1,∗; Krishnan, Arun V. MD, PhD2,3; Zagami, Alessandro S. MD2,3; Tummanapalli, Shyam S. PhD1; Spira, Katherine MD2; Papas, Eric B. PhD, FAAO1; Tavakoli, Azadeh PhD1; Markoulli, Maria PhD, FAAO1. A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migraine. Optometry and Vision Science 102(4):p 183-188, April 2025. | DOI: 10.1097/OPX.0000000000002241